Robust treatment programs key to HIV epidemic

August 2004
Nation's Health;Aug2004, Vol. 34 Issue 6, p17
This article presents the World Health Report 2004--Changing History which was released by the World Health Organization in May. The World Health Organization, United Nations Joint Program on AIDS and several partners are implementing a comprehensive HIV/AIDS strategy that links prevention, treatment, care and support for people living with the virus. The report said treatment is the most neglected element of HIV care in developing countries, even though treatment can most effectively boost prevention efforts and in turn improve health systems and enable poor countries to protect their citizens from a range of health threats. Donor countries and funding agencies such as the Global Fund to Fight AIDS, Tuberculosis and Malaria have pledged$ 20 billion to battle HIV. According to the report, those funds must be used swiftly and in a coordinated way to prolong the lives of millions of children, women and men who will otherwise soon die. AIDS has killed more than 20 million people and is now the leading cause of death and lost years of productive life for adults ages 15-59 worldwide. An estimated 34 million to 46 million people are now living with HIV/AIDS. Without treatment, all of them will die a premature and, in most cases, painful death.


Related Articles

  • Re-emerging and new infectious diseases in Australia: Part 2. Amerena, Vincent // Australasian Dental Practice;Jul/Aug2008, p84 

    The article offers information on HIV/AIDS. This disease has killed more than 20 million people worldwide since being discovered in 1981. According to data released by the World Health Organization, HIV/AIDS is the leading cause of death in people between the age of 15 to 59 years and there are...

  • Implementation of a standardized HIV patient monitoring system in Guyana. Halpern, Mina; Lachmansingh, Bendita; Minior, Thomas; Hasbrouck, La Mar; Persaud, Nicholas; Foo, Astrid // Pan American Journal of Public Health;Aug2010, Vol. 28 Issue 2, p107 

    Objective. To describe the process used to implement a comprehensive, standardized, and reliable national system for data collection for HIV care and treatment in Guyana; to provide examples of the program-level data resulting from implementation; and to highlight the monitoring benefits for...

  • WHO's use of generic antiretrovirals needs support.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p2 

    Presents information on a program implemented by the World Health Organization to increase access to antiretrovirals for HIV-infected individuals in developing countries. Efforts to prove the bioequivalence of generic and brand-name antiretrovirals; Criticism of various international agencies...

  • Ambitious plans to roll out ARVs.  // HIV Australia;Mar-May2004, Vol. 3 Issue 3, p5 

    Reports on the plan to launch antiviral treatment programs at several pilot centres for HIV-positive people across Zimbabwe in 2004. Support of the World Health Organization for the program; Cost of a triple generic drug treatment; Reasons for choosing the pilot sites for the program.

  • Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda. Jaffar, Shabbar; Birungi, Josephine; Grosskurth, Heiner; Amuron, Barbara; Namara, Geoffrey; Nabiryo, Christine; Coutinho, Alex // AIDS Research & Therapy;2008, Vol. 5, Special section p1 

    In a routine service delivery setting in Uganda, we assessed the ability of the WHO clinical stage to accurately identify HIV-infected patients in whom antiretroviral therapy should be started. Among 4302 subjects screened for ART, the sensitivity and specificity (95% CI) of WHO stage III, IV...

  • Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Mengesha, Shibre; Belayihun, Bekele; Kumie, Abera // ISRN Otolaryngology;2014, p1 

    Introduction. ART has improved the survival of HIV-infected patients. However, patients in resource-poor countries have higher mortality rates, particularly the first months after initiating ART. In this study we tried to determine the survival factors in HIV-infected patients treated with HAART...

  • HIV Drug Resistance Early Warning Indicators in Namibia with Updated World Health Organization Guidance. Jonas, Anna; Sumbi, Victor; Mwinga, Samson; DeKlerk, Michael; Tjituka, Francina; Penney, Scott; Jordan, Michael R.; Desta, Tiruneh; Tang, Alice M.; Hong, Steven Y. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: In response to concerns about the emergence of HIV drug resistance (HIVDR), the World Health Organization (WHO) has developed a comprehensive set of early warning indicators (EWIs) to monitor HIV drug resistance and good programme practice at antiretroviral therapy (ART) sites....

  • Factors associated with health-related quality-of-life in HIV-infected Brazilians. Razera, Fernanda; Ferreira, Jair; Bonamigo, Renan Rangel // International Journal of STD & AIDS;Aug2008, Vol. 19 Issue 8, p519 

    Acquired immunodeficiency syndrome HIV/(AIDS) infection has become a chronic disease. This change led to a growing interest in outcomes focusing on the individual, such as health-related quality-of-life (QoL), to assess the impact of treatments. Our study evaluated the impact of the use of...

  • Epidemiology of HIV/AIDS and the scale-up of antiretroviral therapy. Harries, Anthony D.; Takarinda, Kuda; Zachariah, Rony // Africa Health;Jan2016, Vol. 38 Issue 2, p30 

    The article focuses on the new World Health Organization (WHO) guidance for scaling up antiretroviral therapy (ART) for human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS). Topics discussed include the estimated numbers on the HIV/AIDS epidemic, and the...


Read the Article

Other Topics